Molnupac 200/Molnupac 400 Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Concise Prescribing Info

Contents

Molnupiravir

Indications/Uses

Mild to moderate COVID-19 in adults w/ +ve SARS-CoV-2 & who have at least 1 risk factor for developing severe illness.

Click to view Molnupac 200/Molnupac 400 detailed prescribing information

Dosage/Direction for Use

800 mg every 12 hr for 5 days, taken as soon as possible after diagnosis of COVID-19 & w/in 5 days of symptom onset.

Click to view Molnupac 200/Molnupac 400 detailed prescribing information

Overdosage

View Molnupac 200/Molnupac 400 overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food. Swallow whole w/ sufficient amount of fluid (eg, a glass of water), do not open/crush/chew.

Contraindications

Hypersensitivity.

Click to view Molnupac 200/Molnupac 400 detailed prescribing information

Special Precautions

Administration for >5 days has not been established. Women of childbearing potential should use effective contraception during treatment & for 4 days after last dose. Not recommended during pregnancy. Breastfeeding is not recommended during treatment & for 4 days after last dose. Childn <18 yr.

Click to view Molnupac 200/Molnupac 400 detailed prescribing information

Use In Pregnancy & Lactation

Click to view Molnupac 200/Molnupac 400 detailed prescribing information

Adverse Reactions

Dizziness, headache; diarrhoea, nausea.

Click to view Molnupac 200/Molnupac 400 detailed prescribing information

Storage

View Molnupac 200/Molnupac 400 storage conditions for details to ensure optimal shelf-life.

Description

View Molnupac 200/Molnupac 400 description for details of the chemical structure and excipients (inactive components).

Action

View Molnupac 200/Molnupac 400 mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antivirals

ATC Classification

J05 - ANTIVIRALS FOR SYSTEMIC USE ; Used in the systemic treatment of viral infections.
J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors ; Used in the systemic treatment of viral infections.

Regulatory Classification

POM

Presentation/Packing

Form

Molnupac 200 hard cap 200 mg

Packing/Price

1 × 40's;4 × 10's

Form

Molnupac 400 hard cap 400 mg

Packing/Price

2 × 10's

Molnupac 200/Molnupac 400

molnupiravir

Manufacturer:

Pacific Medical

Distributor:

AA Medical